Sixera Pharma | The project
14948
page-template,page-template-full_width,page-template-full_width-php,page,page-id-14948,ajax_fade,page_not_loaded,,qode-theme-ver-13.6,qode-theme-bridge,wpb-js-composer js-comp-ver-5.4.5,vc_responsive

The project

About the project

Sixera Pharma is a biopharmaceutical company based at the Karolinska Institute Science Park in Stockholm. The company was founded to develop basic research findings into treatments for skin diseases.

  • THE DISEASE

    Netherton syndrome (NS) is a rare genetic disease leading to severe skin inflammation and allergic manifestations

  • SYMPTOMS & TREATMENT

    NS is characterized by a combination of three clinical manifestations. The disease is often severe and can be life threatening in newborns and infants.

  • SCIENTIFIC RESEARCH

    The founders of Sixera discovered key genes and the mechanisms regulating skin formation and barrier functions critical for the disease.

DO YOU WANT TO KNOW MORE? DON’T HESITATE TO CONTACT US!